InDevR Revenue and Competitors
Estimated Revenue & Valuation
- InDevR's estimated annual revenue is currently $4.6M per year.
- InDevR's estimated revenue per employee is $77,500
- InDevR's total funding is $10M.
Employee Data
- InDevR has 59 Employees.
- InDevR grew their employee count by 5% last year.
InDevR's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Research and Development Officer | Reveal Email/Phone |
3 | Director Quality Assurance | Reveal Email/Phone |
4 | Chief Operations Officer | Reveal Email/Phone |
5 | Chief Commercial Officer | Reveal Email/Phone |
6 | Director Manufacturing | Reveal Email/Phone |
7 | North American Sales Director | Reveal Email/Phone |
8 | Senior Scientist and Project Manager | Reveal Email/Phone |
9 | Strategic Marketing Manager | Reveal Email/Phone |
10 | Sales Specialist, East Coast | Reveal Email/Phone |
InDevR Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 35 | 483% | $25M | N/A |
#2 | $2M | 13 | 18% | N/A | N/A |
#3 | $3.4M | 22 | 10% | N/A | N/A |
#4 | $68M | 439 | -3% | N/A | N/A |
#5 | $2M | 13 | 30% | N/A | N/A |
#6 | $4M | 26 | 8% | N/A | N/A |
#7 | $2.7M | 35 | -10% | $23.2M | N/A |
#8 | $5.3M | 34 | 70% | N/A | N/A |
#9 | $1.7M | 11 | -8% | N/A | N/A |
#10 | $3.1M | 20 | -17% | N/A | N/A |
What Is InDevR?
InDevR is a global leader in progressive new analytical technologies that enable accelerated development and manufacturing of vaccines and other biotherapeutics. Key products include our VaxArray portfolio of our game-changing multiplexed potency assays for vaccines and the Cypher One system for digital imaging and automated interpretation of hemagglutination assays.
keywords:N/A$10M
Total Funding
59
Number of Employees
$4.6M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
InDevR News
... Arrayit, Takara Bio, BioGenex, LC Sciences, US Biomax, AXO Science, BioCat, Cepheid, GE Healthcare, InDevR & Qiagen etc.
InDevR, Inc., a Boulder, CO-based biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, raised $7m in Series A round of equity financing. Adjuvant Capital made the investment. The company intends to use th ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.1M | 59 | 9% | N/A |
#2 | $11.7M | 59 | 26% | N/A |
#3 | $7.7M | 59 | N/A | N/A |
#4 | $4.6M | 59 | -25% | $29M |
#5 | $13.4M | 60 | 50% | $71M |